Review of biologics, biosimilars, and intended copies in rheumatology, and current practice in Iraq

Biologic therapies are an important option in the treatment of patients with rheumatic disease. As the development of potential biosimilars increases, many countries are following the guidelines developed by the WHO, European Medicines Agency, or US Food and Drug Administration to create country-spe...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Open Access Rheumatol
Autori principali: Al Ani, Nizar Abdulateef, Gorial, Faiq I, Al-Sulaitti, Saad, Humadi, Jasmine Abbas, Awadh, Nabaa Ihsan, Mounir, Mohamed, Dershaby, Yasser El, Jones, Heather, Sunna, Nancy
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2018
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6307490/
https://ncbi.nlm.nih.gov/pubmed/30613169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OARRR.S176965
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi